or Try an Advanced Search...

    Technical Analysis for BCTX - BriaCell Therapeutics Corp.

    Grade Last Price % Change Price Change
    F 0.74 23.23% 0.14
    BCTX closed up 5.37 percent on Wednesday, November 20, 2024, on 21 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: Dec 12
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical BCTX trend table...
    Date Alert Name Type % Chg
    Bullish Engulfing Bullish 23.23%
    Stochastic Buy Signal Bullish 23.23%
    Wide Bands Range Expansion 23.23%
    Oversold Stochastic Weakness 23.23%
    Narrow Range Bar Range Contraction 29.85%
    Wide Bands Range Expansion 29.85%
    Oversold Stochastic Weakness 29.85%
    NR7 Range Contraction 24.74%
    Narrow Range Bar Range Contraction 24.74%
    Inside Day Range Contraction 24.74%
    Older End-of-Day Signals for BCTX ...

       Recent Intraday Alerts

    Alert Time
    2x Volume Pace about 2 hours ago
    Rose Above 50 DMA about 2 hours ago
    50 DMA Resistance about 2 hours ago
    1.5x Volume Pace about 2 hours ago
    Up 2 ATRs about 2 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    BCTX Chart by TradingView
    Basic chart:

    Profile

    BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Cancer Clinical Medicine Immune System Immunotherapy Oncology Breast Cancer Treatment Of Breast Cancer Immune Checkpoint National Cancer Institute Advanced Breast Cancer

    Is BCTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 21 BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer Study
    Nov 8 BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference
    Nov 4 BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13
    Oct 22 BriaCell Therapeutics: High-Potential In Phase 3 Metastatic Breast Cancer, But Financing Concerns
    Oct 22 BriaCell Higher as it Reports "Standard-Beating" Survival Data From Phase 2 Study
    Oct 22 BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data
    Oct 15 BriaCell gains after update on late-stage trial for lead asset
    Oct 15 BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study
    Oct 2 BriaCell Therapeutics Announces Closing of $5 Million Offering
    Oct 2 Why JD.com Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
    See more BCTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.97
    52 Week Low 0.4641
    Average Volume 2,942,501
    200-Day Moving Average 1.55
    50-Day Moving Average 0.78
    20-Day Moving Average 0.72
    10-Day Moving Average 0.63
    Average True Range 0.07
    RSI (14) 36.71
    ADX 23.53
    +DI 16.40
    -DI 28.04
    Chandelier Exit (Long, 3 ATRs) 0.73
    Chandelier Exit (Short, 3 ATRs) 0.78
    Upper Bollinger Bands 0.92
    Lower Bollinger Band 0.51
    Percent B (%b) 0.22
    BandWidth 57.73
    MACD Line -0.07
    MACD Signal Line -0.05
    MACD Histogram -0.0138
    Fundamentals Value
    Market Cap 9.63 Million
    Num Shares 16 Million
    EPS -1.73
    Price-to-Earnings (P/E) Ratio -0.35
    Price-to-Sales 0.00
    Price-to-Book 23.02
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.68
    Resistance 3 (R3) 0.67 0.64 0.67
    Resistance 2 (R2) 0.64 0.63 0.65 0.66
    Resistance 1 (R1) 0.62 0.61 0.63 0.63 0.66
    Pivot Point 0.59 0.59 0.60 0.60 0.59
    Support 1 (S1) 0.57 0.57 0.58 0.58 0.55
    Support 2 (S2) 0.54 0.56 0.55 0.54
    Support 3 (S3) 0.52 0.54 0.54
    Support 4 (S4) 0.53